- Home
- ARTV vs NKSH Comparison
ARTV vs NKSH Comparison
Compare ARTV & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- NKSH
- Stock Information
- Founded
- ARTV 2019
- NKSH 1891
- Country
- ARTV United States
- NKSH United States
- Employees
- ARTV N/A
- NKSH N/A
- Industry
- ARTV
- NKSH Major Banks
- Sector
- ARTV
- NKSH Finance
- Exchange
- ARTV NYSE
- NKSH Nasdaq
- Market Cap
- ARTV 186.1M
- NKSH 190.8M
- IPO Year
- ARTV 2024
- NKSH N/A
- Fundamental
- Price
- ARTV $3.77
- NKSH $27.51
- Analyst Decision
- ARTV Strong Buy
- NKSH Strong Buy
- Analyst Count
- ARTV 6
- NKSH 1
- Target Price
- ARTV $21.00
- NKSH $38.00
- AVG Volume (30 Days)
- ARTV 83.1K
- NKSH 7.8K
- Earning Date
- ARTV 03-04-2025
- NKSH 01-23-2025
- Dividend Yield
- ARTV N/A
- NKSH 5.49%
- EPS Growth
- ARTV N/A
- NKSH N/A
- EPS
- ARTV N/A
- NKSH 1.24
- Revenue
- ARTV $2,601,000.00
- NKSH $44,130,000.00
- Revenue This Year
- ARTV N/A
- NKSH N/A
- Revenue Next Year
- ARTV N/A
- NKSH $9.78
- P/E Ratio
- ARTV N/A
- NKSH $22.24
- Revenue Growth
- ARTV N/A
- NKSH N/A
- 52 Week Low
- ARTV $3.37
- NKSH $26.00
- 52 Week High
- ARTV $17.31
- NKSH $35.00
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- NKSH 38.28
- Support Level
- ARTV N/A
- NKSH $28.51
- Resistance Level
- ARTV N/A
- NKSH $28.88
- Average True Range (ATR)
- ARTV 0.00
- NKSH 0.63
- MACD
- ARTV 0.00
- NKSH -0.11
- Stochastic Oscillator
- ARTV 0.00
- NKSH 0.00
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.